We believe this site might serve you best:

United States

English Continue

This country code will remain if no action is taken to change it.

Don't see your country?
Promega Corporation

Myristoylated Protein Kinase C Peptide Inhibitor

Myristoylated Protein Kinase C (PKC) Peptide Inhibitor, Myr. RFARKGALRQKNV (MW = 1,754 daltons), specifically inhibits calcium- and phospholipid-dependent protein kinase C (PKC). It is based on the pseudosubstrate region of PKC-α and PKC-β. It is supplied ready for use in kinase reactions. Greater than 75% inhibition of PKC activity is usually obtained with 50μM Myristoylated PKC Peptide Inhibitor.


  • Concentration: 10mg/ml (peptide).
  • Molarity: 4.3mM.
  • Peptide Content: ≥ 70%. The mass of the peptide is verified by FAB/MS.
  • Molecular Weight: 1,754Da.

Expand to Read More »

  • Prices valid for US customers only
Product Size Conc. Catalog # *List Price QTY Add to Cart

Myristoylated Protein Kinase C Peptide Inhibitor

- V5691 $ 99.00 Add to cart

Storage Conditions

Store at –20°C.

For product intended use please see Patents & Disclaimers tab.

It appears that you have Javascript disabled. Our website requires Javascript to function correctly. For the best browsing experience, please enable Javascript.

Scientists at Your Service

Scientists at Your Service

We offer a range of services to help you succeed using Promega technologies. From product training to set up of automated systems and development of custom applications—our scientific support goes beyond the basics.

Ask us! We are here to help you.